Literature DB >> 11401482

Perivascular cells regulate endothelial membrane type-1 matrix metalloproteinase activity.

M A Lafleur1, P A Forsyth, S J Atkinson, G Murphy, D R Edwards.   

Abstract

Angiogenic stimuli selectively induced expression of membrane type-1 matrix metalloproteinase (MT1-MMP) transcripts and protein in human umbilical vein endothelial cells (HUVECs). Pro-MMP-2 activation was blocked by treatment with tissue inhibitor of metalloproteinases-2 (TIMP-2), but not by TIMP-1 or inhibitors of other proteinase classes. Anti-MT1-MMP antibodies abrogated recombinant pro-MMP-2 activation by plasma membranes, indicating that MT1-MMP is the main mediator of pro-MMP-2 activation in HUVECs. Cocultures of HUVECs with smooth muscle cells (SMC) or pericytes (PC) resulted in the suppression of HUVEC pro-MMP-2 activation. Treatment of A10 SMC conditioned media with a neutralising anti-TIMP-2 antibody prevented the suppression of HUVEC pro-MMP-2 activation. Inhibition of HUVEC MT1-MMP function by PC and SM3 SMC correlated with elevated TIMP-3 expression. Thus, perivascular supporting cells regulate the functions of proangiogenic MMPs elaborated by endothelial cells via selective expression of TIMPs. This interplay may be important for maintenance of blood vessel architecture and neovascularisation. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11401482     DOI: 10.1006/bbrc.2001.4596

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

Review 1.  Matrix metalloproteinase control of capillary morphogenesis.

Authors:  Cyrus M Ghajar; Steven C George; Andrew J Putnam
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2008       Impact factor: 1.807

Review 2.  Chemistry and pharmacology of 4-hydroxylonchocarpin: a review.

Authors:  Victor Kuete; Jaures A K Noumedem; Frederic Nana
Journal:  Chin J Integr Med       Date:  2013-06-20       Impact factor: 1.978

3.  Activation of proMMP-2 by U46619 occurs via involvement of p(38)MAPK-NFκB-MT1MMP signaling pathway in pulmonary artery smooth muscle cells.

Authors:  Animesh Chowdhury; Soumitra Roy; Tapati Chakraborti; Kuntal Dey; Sajal Chakraborti
Journal:  Mol Cell Biochem       Date:  2013-09-25       Impact factor: 3.396

4.  Cross-talk between NADPH oxidase-PKCα-p(38)MAPK and NF-κB-MT1MMP in activating proMMP-2 by ET-1 in pulmonary artery smooth muscle cells.

Authors:  Jaganmay Sarkar; Animesh Chowdhury; Tapati Chakraborti; Sajal Chakraborti
Journal:  Mol Cell Biochem       Date:  2016-02-24       Impact factor: 3.396

5.  Fluid shear stress modulates endothelial cell invasion into three-dimensional collagen matrices.

Authors:  Hojin Kang; Kayla J Bayless; Roland Kaunas
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-09-19       Impact factor: 4.733

6.  Bone marrow-derived mesenchymal stem cells enhance angiogenesis via their α6β1 integrin receptor.

Authors:  Bita Carrion; Yen P Kong; Darnell Kaigler; Andrew J Putnam
Journal:  Exp Cell Res       Date:  2013-09-19       Impact factor: 3.905

7.  Pericytes on the tumor vasculature: jekyll or hyde?

Authors:  Keith D Barlow; Anne M Sanders; Shay Soker; Suleyman Ergun; Linda J Metheny-Barlow
Journal:  Cancer Microenviron       Date:  2012-03-31

8.  Involvement of metalloprotease-2 in the development of human brain microvessels.

Authors:  Francesco Girolamo; Daniela Virgintino; Mariella Errede; Carmen Capobianco; Nunzia Bernardini; Mirella Bertossi; Luisa Roncali
Journal:  Histochem Cell Biol       Date:  2004-09-15       Impact factor: 4.304

Review 9.  Molecular mediators of angiogenesis.

Authors:  Areck A Ucuzian; Andrew A Gassman; Andrea T East; Howard P Greisler
Journal:  J Burn Care Res       Date:  2010 Jan-Feb       Impact factor: 1.845

Review 10.  Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: contrasting, overlapping and compensatory functions.

Authors:  Elena I Deryugina; James P Quigley
Journal:  Biochim Biophys Acta       Date:  2009-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.